| Announce Date | 10/28/2025 |
| EPS Normalized Actual | $1.98 (Miss by $-0.01) |
| EPS GAAP Actual | $1.98 (Miss by $-0.01) |
| Revenue Actual | $0.4252B |
| Revenue Surprise | Beat by $425.2M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $1.81702 |
| EPS GAAP Estimate | $1.81702 |
| Revenue Estimate | $0.406499295B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2027 | 9.40398 | 21.08 | 9.26142 | 9.53533 | 1 |
| Dec 2026 | 7.75208 | 25.57 | 7.66929 | 7.86363 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 2 | 0.31016 | 0.4252B | 9.08% | 50.61M |
| FQ2 2025 (Jun 2025) | 2.02 | 0.34162 | 0.4246B | 14.01% | 63.21M |
| FQ1 2025 (Mar 2025) | 1.59 | 0.20138 | 0.3827B | 14.74% | 47.28M |
| FQ4 2024 (Dec 2024) | 1.43 | 0.0992 | 0.3677B | 15.07% | 16.79M |
| FQ3 2024 (Sep 2024) | 1.76 | 1.76 | 0.3866B | 10.17% | 386.6M |
| FQ2 2024 (Jun 2024) | 1.5 | 1.5 | 0.3651B | 10.87% | 365.1M |
| FQ1 2024 (Mar 2024) | 1.37 | 1.37 | 0.3263B | 4.93% | 326.3M |
| FQ4 2023 (Dec 2023) | 1.07 | 1.07 | 0.3123B | 2.5% | 312.3M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
1.81702
Consensus Revenue Estimates
0.406499295B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.13123 | -- | 2.09396 | 2.16417 | 2 |
| FQ3 2027 (Sep 2027) | 2.67951 | -- | 2.63265 | 2.72093 | 2 |
| FQ2 2027 (Jun 2027) | 2.57339 | -- | 2.52839 | 2.61317 | 2 |
| FQ1 2027 (Mar 2027) | 2.12032 | -- | 2.08324 | 2.1531 | 2 |
| FQ4 2026 (Dec 2026) | 1.93148 | -- | 1.87624 | 2.00919 | 3 |
| FQ3 2026 (Sep 2026) | 2.32138 | 13.84 | 2.25499 | 2.41478 | 3 |
| FQ2 2026 (Jun 2026) | 2.08546 | 3.14 | 2.02582 | 2.16937 | 3 |
| FQ1 2026 (Mar 2026) | 1.81702 | 12.49 | 1.76506 | 1.89013 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.46B | -- | 0.45B | 0.46B | 2 |
| FQ3 2027 (Sep 2027) | 0.5B | -- | 0.49B | 0.5B | 2 |
| FQ2 2027 (Jun 2027) | 0.49B | -- | 0.48B | 0.49B | 2 |
| FQ1 2027 (Mar 2027) | 0.44B | -- | 0.44B | 0.45B | 2 |
| FQ4 2026 (Dec 2026) | 0.42B | -- | 0.41B | 0.43B | 4 |
| FQ3 2026 (Sep 2026) | 0.46B | 6.77 | 0.45B | 0.47B | 4 |
| FQ2 2026 (Jun 2026) | 0.43B | 2.27 | 0.42B | 0.45B | 4 |
| FQ1 2026 (Mar 2026) | 0.41B | 5.85 | 0.4B | 0.42B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.68984 | 2 | 0.31016 | 15.51% |
| FQ2 2025 (Jun 2025) | 1.67838 | 2.02 | 0.34162 | 16.91% |
| FQ1 2025 (Mar 2025) | 1.38862 | 1.59 | 0.20138 | 12.67% |
| FQ4 2024 (Dec 2024) | 1.3308 | 1.43 | 0.0992 | 6.94% |
| FQ3 2024 (Sep 2024) | 1.76 | 1.76 | 100% | |
| FQ2 2024 (Jun 2024) | 1.5 | 1.5 | 100% | |
| FQ1 2024 (Mar 2024) | 1.37 | 1.37 | 100% | |
| FQ4 2023 (Dec 2023) | 1.07 | 1.07 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.37B | $0.43B | $50.61M | 11.9% |
| FQ2 2025 (Jun 2025) | $0.36B | $0.42B | $63.21M | 14.89% |
| FQ1 2025 (Mar 2025) | $0.34B | $0.38B | $47.28M | 12.35% |
| FQ4 2024 (Dec 2024) | $0.35B | $0.37B | $16.79M | 4.57% |
| FQ3 2024 (Sep 2024) | $0B | $0.39B | $386.6M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.37B | $365.1M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.33B | $326.3M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.31B | $312.3M | 100% |